ABT

SEC source: 0001104659-08-034126 · a4.xml · nonDerivative · entry 2

Tyree James L · CIK 0001324991 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,966

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-08-034126 · a4.xml · nonDerivative · entry 1

Tyree James L · CIK 0001324991 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,269

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-08-034127 · a4.xml · derivative · entry 9

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,113

Underlying: Common Shares · 17,113 shares

Expires 2010-02-10

F1 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001104659-08-034127 · a4.xml · derivative · entry 8

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,873

Underlying: Common Shares · 34,873 shares

Expires 2009-02-11

F1 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001104659-08-034127 · a4.xml · derivative · entry 7

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 3,065 shares

Expires 2010-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001104659-08-034127 · a4.xml · derivative · entry 6

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,970

Underlying: Common Shares · 20,167 shares

Expires 2010-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001104659-08-034127 · a4.xml · derivative · entry 5

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 40,433 shares

Expires 2009-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001104659-08-034127 · a4.xml · nonDerivative · entry 4

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,095

SEC source: 0001104659-08-034127 · a4.xml · nonDerivative · entry 3

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,081

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-08-034127 · a4.xml · nonDerivative · entry 2

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,849

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-08-034127 · a4.xml · nonDerivative · entry 1

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,416

SEC source: 0001104659-08-031404 · a4.xml · derivative · entry 8

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 390

Underlying: Common Shares · 390 shares

Expires 2010-02-10

F2 · security: Employee stock option, including replacement option feature, granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001104659-08-031404 · a4.xml · derivative · entry 7

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,220

Underlying: Common Shares · 16,220 shares

Expires 2014-02-19

F2 · security: Employee stock option, including replacement option feature, granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001104659-08-031404 · a4.xml · derivative · entry 6

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 447 shares

Expires 2010-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option, including replacement option feature, granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001104659-08-031404 · a4.xml · derivative · entry 5

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,454

Underlying: Common Shares · 18,789 shares

Expires 2014-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option, including replacement option feature, granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001104659-08-031404 · a4.xml · nonDerivative · entry 3

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,608

SEC source: 0001104659-08-031404 · a4.xml · nonDerivative · entry 2

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,218

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-08-031404 · a4.xml · nonDerivative · entry 1

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-08-029166 · a4.xml · nonDerivative · entry 1

Tyree James L · CIK 0001324991 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,477

SEC source: 0001104659-08-030000 · a4.xml · nonDerivative · entry 1

Mason Heather L · CIK 0001432601 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,300

F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001104659-08-030001 · a4.xml · nonDerivative · entry 2

Hance Robert B · CIK 0001383841 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,075

F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001104659-08-028071 · a4.xml · nonDerivative · entry 1

FARRELL W JAMES · CIK 0001021872 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,774

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-028073 · a4.xml · nonDerivative · entry 1

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,863

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-028074 · a4.xml · nonDerivative · entry 1

ROBERTS ROY S · CIK 0001200813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,155

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-028079 · a4.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,647

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-028083 · a4.xml · nonDerivative · entry 1

TILTON GLENN F · CIK 0001194624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,647

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-028081 · a4.xml · nonDerivative · entry 1

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,806

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-028087 · a4.xml · nonDerivative · entry 1

OSBORN WILLIAM A · CIK 0001171797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,917

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-028086 · a4.xml · nonDerivative · entry 1

AUSTIN ROXANNE S · CIK 0001061632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,507

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-028089 · a4.xml · nonDerivative · entry 1

DALEY WILLIAM M · CIK 0001183865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,163

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-028090 · a4.xml · nonDerivative · entry 1

POWELL BOONE JR · CIK 0001232973 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,692

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-028091 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,394

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-028092 · a4.xml · derivative · entry 2

OWEN DAVID · CIK 0001239142 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,985

Underlying: common shares · 5,985 shares

Expires 2018-04-25

F2 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001104659-08-028092 · a4.xml · nonDerivative · entry 1

OWEN DAVID · CIK 0001239142 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,623

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-026950 · a4.xml · nonDerivative · entry 1

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,438

SEC source: 0001104659-08-027468 · a4.xml · nonDerivative · entry 1

Bohuon Olivier · CIK 0001360215 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,008

F1 · kind: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001104659-08-026948 · a4.xml · derivative · entry 4

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 5,124 shares

Expires 2008-04-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001104659-08-026948 · a4.xml · nonDerivative · entry 3

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,946

SEC source: 0001104659-08-026948 · a4.xml · nonDerivative · entry 2

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,544

SEC source: 0001104659-08-026948 · a4.xml · nonDerivative · entry 1

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,070

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-08-030001 · a4.xml · nonDerivative · entry 1

Hance Robert B · CIK 0001383841 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,075

SEC source: 0001104659-08-025240 · a4.xml · nonDerivative · entry 1

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,541

SEC source: 0001104659-08-022158 · a4.xml · derivative · entry 11

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 5,124 shares

Expires 2008-04-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program.

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 8

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,477

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 7

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,151

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 6

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,851

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 5

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,751

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 4

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,051

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 3

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,301

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 2

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,501